FindTrial
Sign In

Cost-benefit analysis of laminar flow bed to prevent nosocomial infection for acute leukemia patients

Cost-benefit analysis of laminar flow bed to prevent nosocomial infection for acute leukemia patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OON-14005370
Enrollment
Unknown
Registered
2014-10-22
Start date
2014-11-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute leukmeia

Interventions

Case series:laminar flow bed

Sponsors

Department of Hematology, Tangdu Hospital, Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 90 Years

Inclusion criteria

Inclusion criteria: 1. Primary AML, MDS related AML, myeloid blast crisis of CML; 2. Need intravenous chemotherapy.

Exclusion criteria

Exclusion criteria: 1. There has been a clear new (activity) infection; 2. Expected survival time is less than a month; 3. People with low compliance or whom the doctor think cannot cooperate.

Design outcomes

Primary

MeasureTime frame
cost-effect analysis;—

Contacts

Public ContactLi Guohui
lghab@126.com+86 13892888604

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026